UiPath stock has tumbled as optimism around its automation software has been overtaken by concern about artificial intelligence.

UiPath shares have had a tough start to the year, but the company has a big potential opportunity ahead.

UiPath (NYSE:PATH) declined approximately 6% in today’s session, trading below $12 midday on Thursday. The selloff is puzzling on the surface. UiPath just posted a quarter that beat expectations on ...

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath (NYSE:PATH) and Deloitte have expanded their alliance, introducing Deloitte's Agentic ERP offering with UiPath's agentic automation embedded into ERP workflows. The collaboration centers on ...

Enterprise automation budgets are shifting from point tools to platforms. Buyers want governance, reuse, and faster time to value across UI, API and document-heavy work. UiPath PATH is leaning into ...

Founded in Romania in 2005, UiPath develops AI software that is able to automate boring activities like extracting data, filling documents, or updating databases. The fast-growing market of Robotic ...

Every technology company wants a slice of the Artificial Intelligence (AI) pie. More accurately, every tech company wants to show that it has a healthy AI development stream bringing the benefits of ...